Registro de Citas

Cita APA (7a ed.)
Armstrong, A. W., Park, S. H., Patel, V., Hogan, M., Wang, W., Davidson, D., & Chirikov, V. (2023). Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis. Adis, Springer Healthcare.
Cita Chicago Style (17a ed.)
Armstrong, April W., Sang Hee Park, Vardhaman Patel, Malcolm Hogan, Wei-Jhih Wang, David Davidson, y Viktor Chirikov. Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis. Adis, Springer Healthcare, 2023.
Cita MLA (9a ed.)
Armstrong, April W., et al. Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis. Adis, Springer Healthcare, 2023.
Precaución: Estas citas no son 100% exactas.